InfoBionic Raises $17M Series B

April 8, 2014: InfoBionic™, an emerging digital health company focused on creating superior patient monitoring solutions for chronic disease management, today announced that it has closed the first tranche of a $17 million Series B financing, which was led by Safeguard Scientifics, Inc. (NYSE: SFE). Proceeds from the financing will enable InfoBionic to commercialize its MoMe™ System, a remote patient monitoring platform for cardiac arrhythmia detection, in Europe and the United States.

 

Press Release